February 2025 saw a mix of all-new models, feature upgrades, and special editions with SUVs dominating the list.

The month of February multiple new launches in the India passenger vehicle segment starting from Kia Syros to premium models ...

Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...

With a mere difference of Rs 10,000, should you choose the mid-spec variant of Syros or the Sonet? The Kia Syros was launched ...

India’s passenger vehicle market continued to show resilience in Feb 2025, with total sales of the top 10 best-selling models ...

Kia India’s growth is not limited to domestic markets, as it exported 2,042 units of its ‘Made in India’ vehicles to over 70 ...

The Kia Sonet was the brand's top-seller in February followed by the Seltos and Carens. The Kia Syros has been a strong ...

India's sub-4 metre compact SUV segment is fiercely competitive, offering some formidable options like the Maruti Suzuki ...

Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...

The Seltos overall gains more value and the panoramic sunroof equipped model is under Rs 13 lakh. The variant line-up and the ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its ...

Equities research analysts at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” ...